We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacteriophage Infection Mediated by Molecules from Susceptible Organisms

By LabMedica International staff writers
Posted on 26 Jan 2017
A team of Israeli molecular microbiologists has found that bacteria that are resistant to infection by bacteriophages can lose this resistance when incubated together with susceptible bacteria.

The mechanism by which bacteria that are resistant to infection by phages become susceptible had not been well studied. More...
To elucidate this mechanism, investigators at The Hebrew University of Jerusalem investigated phage dynamics in communities harboring phage-resistant (R) and sensitive (S) Bacillus subtilis bacteria.

Using cultures of B. subtilis and its lytic phage SPP1, they demonstrated that R cells, lacking SPP1 receptor, could be lysed by SPP1 when co-cultured with S cells. This unanticipated lysis was triggered in part by phage lytic enzymes released from nearby infected cells. They also discovered that occasionally phages could invade R cells, a phenomenon they termed acquisition of sensitivity (ASEN).

The investigators reported in the January 12, 2017, issue of the journal Cell that ASEN was mediated by R cells transiently gaining phage attachment molecules from neighboring S cells and that this molecular exchange was driven by membrane vesicles. They speculated that this exchange of phage attachment molecules could even occur in an interspecies fashion, enabling phage adsorption to non-host species, providing an unexplored route for horizontal gene transfer (HGT).

"In the present study, we show for the first time how bacteria entirely resistant to a given phage become susceptible upon co-incubation with sensitive bacteria. Phage invasion into resistant cells could have a major impact on transfer of antibiotic resistance and virulence genes among bacteria. This aspect should be carefully considered when employing phage therapy, as phage infection of a given species may result in gene transmission into neighboring bacteria resistant to the phage," said senior author Dr. Sigal Ben-Yehuda, professor of microbiology and molecular genetics at The Hebrew University of Jerusalem.


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.